{"id":"extra-fine-hydrofluoroalkane-beclomethasone-mdi","safety":{"commonSideEffects":[{"rate":"10%","effect":"Oral thrush"},{"rate":"5%","effect":"Headache"},{"rate":"5%","effect":"Nausea"},{"rate":"2%","effect":"Vomiting"},{"rate":"2%","effect":"Cough"},{"rate":"1%","effect":"Dysphonia"},{"rate":"1%","effect":"Hoarseness"},{"rate":"1%","effect":"Pneumonia"},{"rate":"1%","effect":"Sinusitis"},{"rate":"1%","effect":"Upper respiratory tract infection"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Beclomethasone acts as a potent glucocorticoid receptor agonist, which leads to anti-inflammatory and immunosuppressive effects.","oneSentence":"Glucocorticoid receptor agonist","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T04:00:06.754Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Asthma"},{"name":"Chronic obstructive pulmonary disease (COPD)"}]},"trialDetails":[{"nctId":"NCT01141439","phase":"","title":"Real-world Effectiveness and Cost-effectiveness of Leading Inhaled Corticosteroids in Asthma Management","status":"COMPLETED","sponsor":"Research in Real-Life Ltd","startDate":"2001-01","conditions":"Asthma","enrollment":815377},{"nctId":"NCT01729351","phase":"","title":"Qvar Therapy in Smoking Asthmatics","status":"COMPLETED","sponsor":"Research in Real-Life Ltd","startDate":"2011-11","conditions":"Asthma, Smoking","enrollment":7195},{"nctId":"NCT01400217","phase":"","title":"Qvar Versus Clenil, a General Practice Research Database Study","status":"COMPLETED","sponsor":"Research in Real-Life Ltd","startDate":"1991-01","conditions":"Asthma","enrollment":56985},{"nctId":"NCT01141452","phase":"","title":"Real-life Effectiveness and Cost-effectiveness of Qvar Versus FP and BDP in the Management of COPD","status":"COMPLETED","sponsor":"Research in Real-Life Ltd","startDate":"2001-01","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":815377}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Qvar®"],"phase":"phase_2","status":"active","brandName":"Extra-fine hydrofluoroalkane beclomethasone MDI","genericName":"Extra-fine hydrofluoroalkane beclomethasone MDI","companyName":"Research in Real-Life Ltd","companyId":"research-in-real-life-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Glucocorticoid receptor agonist Used for Asthma, Chronic obstructive pulmonary disease (COPD).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}